ArticleFrontiers in pharmacology2025
Ensemble learning approach with explainable AI for improved heart disease prediction.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Ensemble learning for predicting birth trauma using high-dimensional data in the neonatal intensive care unit.Scientific reports · 2026Article
- An interpretable weighted ensemble based on routinely collected clinical data for the accurate prediction of axillary lymph node metastasis.Quantitative imaging in medicine and surgery · 2026Article
- Machine learning prediction model for surgical site infections after major abdominal surgery.Patient safety in surgery · 2026Article
- Machine learning-based prediction of prolonged length of stay in older patients with type 2 diabetes mellitus and cardiovascular disease.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Heart disease remains a leading cause of global morbidity and mortality, motivating the development of predictive models that are both accurate and clinically interpretable. We introduce the Interpretable Ensemble Learning Framework (IELF), which integrates Explainable Boosting Machines (EBM) with XGBoost, SHAP-based explanations, and LIME for enhanced local interpretability. Methods: IELF was evaluated on two benchmark datasets: Cleveland (n = 303) and Framingham (n = 4,240). Model assessment included 5-fold cross-validation, held-out test sets, calibration, subgroup analyses, and explanation stability evaluation using Kendall's τ and Overlap@10. Results: IELF achieved robust discrimination (AUC 0.899, accuracy 88.5% on Cleveland; AUC 0.696, accuracy 82.6% on Framingham) with balanced precision-recall profiles. Compared with EBM, IELF significantly improved recall, F1, and AUC on the Framingham dataset (p < 0.05), while differences versus XGBoost were less consistent. IELF produced transparent feature rankings aligned with established cardiovascular risk factors and stable explanations across folds. Discussion: IELF is, to our knowledge, the first framework to combine EBM and XGBoost with SHAP and LIME under strict nested cross-validation and calibration procedures. Although headline accuracies are lower than some recent >97% reports, IELF was developed under stricter methodological controls that enhance reproducibility, interpretability, and clinical reliability. These findings position IELF as a trustworthy benchmark for translational AI in cardiovascular risk prediction, complementing high-accuracy but less transparent models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.